Dark | Light
[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]

![AponiaAnalytics Avatar](https://lunarcrush.com/gi/w:24/cr:twitter::1816152863069925376.png) aponia_analytics [@AponiaAnalytics](/creator/twitter/AponiaAnalytics) on x 4969 followers
Created: 2025-07-20 18:07:34 UTC

🦉 Persistence rate in women using oral semaglutide was XXXX% over one year. Despite GI intolerance in nearly X in 10, overall adherence was high and similar to previous GLP-1 RA studies.

#GLP1 #Tirzepatide $NVO $LLY $AZN $SNY $GSK $PFE $RHHBY $ZLDPF


XXX engagements

![Engagements Line Chart](https://lunarcrush.com/gi/w:600/p:tweet::1946995411446648973/c:line.svg)

**Related Topics**
[pfe](/topic/pfe)
[manat](/topic/manat)
[$zldpf](/topic/$zldpf)
[$rhhby](/topic/$rhhby)
[$gsk](/topic/$gsk)
[$sny](/topic/$sny)
[$lly](/topic/$lly)
[women](/topic/women)

[Post Link](https://x.com/AponiaAnalytics/status/1946995411446648973)

[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]

AponiaAnalytics Avatar aponia_analytics @AponiaAnalytics on x 4969 followers Created: 2025-07-20 18:07:34 UTC

🦉 Persistence rate in women using oral semaglutide was XXXX% over one year. Despite GI intolerance in nearly X in 10, overall adherence was high and similar to previous GLP-1 RA studies.

#GLP1 #Tirzepatide $NVO $LLY $AZN $SNY $GSK $PFE $RHHBY $ZLDPF

XXX engagements

Engagements Line Chart

Related Topics pfe manat $zldpf $rhhby $gsk $sny $lly women

Post Link

post/tweet::1946995411446648973
/post/tweet::1946995411446648973